Vynleads (VYND) Receivables (2019 - 2024)
Vynleads (VYND) reported Receivables of $9434.0 for Q4 2024, down 46.29% on a QoQ basis from $17564.0 in Q4 2020.
Vynleads (VYND) has 3 years of Receivables data on file, last reported at $9434.0 in Q4 2024.
- Quarterly Receivables changed N/A year-over-year to $9434.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $9434.0 (changed N/A YoY) and the FY2024 annual result came in at $9434.0, changed N/A from the prior year.
- Receivables retreated to $9434.0 in Q4 2024 per VYND's latest filing, from $17564.0 in the prior quarter.
- Across five years, Receivables topped out at $48514.0 in Q1 2020 and bottomed at $9434.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.31 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 1.17 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 122.00 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 120.88 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 146.98 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 172.53 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 56.14 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 513.68 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 284.42 Mn |
| 10 | Vynleads | - | - | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 9,434.00 |
| Dec 31, 2020 | 17,564.00 |
| Sep 30, 2020 | 30,904.00 |
| Jun 30, 2020 | 39,545.00 |
| Mar 31, 2020 | 48,514.00 |
| Dec 31, 2019 | 45,919.00 |